Intracellular cytokine profile in T-cell subsets of multiple sclerosis patients: different features in primary progressive disease

Abstract

Objective: To evaluate the expression of cytokines in both CD4⁺ and CD8⁺ T cells derived from peripheral blood of untreated multiple sclerosis (MS) patients with either relapsing-remitting (RR), secondary progressive (SP) or primary progressive (PP) MS and healthy controls (HC). Background: MS is an immune-mediated disease and cytokines have been hypothesized to contribute significantly to disease progression. Compared to the relapse-onset (RR, SP) form of the disease, PPMS patients have different clinical, immunological and pathological features. Surprisingly, the ability of their circulating T cells to produce immunoregulatory cytokines has not been extensively studied so far. Methods: Seventy-two MS patients (24 RR, 26 SP, 22 PP) and 34 HC were studied. Stimulated peripheral blood derived CD4⁺ and CD8⁺ T cells were analyzed for IFN-g, IL-2, TNF-a, IL-4, IL-10 and IL-13 production. Results: MS patients express significantly more CD4⁺ and CD8⁺ T cells producing IFN-g compared to HC. Compared to the other forms of the disease, PPMS patients display a significant decrease in CD4⁺ T cells producing IL-2, IL-13 and TNF-a and a significant increase in CD8⁺ T cells producing IL-4 and IL-10. Conclusions: The data presented here demonstrate that patients with PPMS express less pro- and more anti-inflammatory cytokine producing T cells compared to the relapse-onset form of the disease, confirming the view on PPMS as a distinct disease entity.

Keywords

T cells cytokines primary progressive MS

Get full access to this article

View all access options for this article.

References

Martino G , Hartung HP. (1999) Immunopathogenesis of multiple sclerosis: the role of T cells . Curr Opin Neurol 12: 309-321 .

Romagnani S. (1991) Human Th1 and Th2 subsets: doubt no more . Immunol Today 12: 256-257 .

Van der Graaff WL , Prins APA , Dijkmans BAC , Van Lier RAW. (1998) Prognostic value of Th1/Th2 ratio in rheumatoid arthritis . Lancet 351: 1931-1931 .

Charlton B , Lafferty KJ. (1995) The Th1/Th2 balance in autoimmunity . Curr Opin Immunol 7: 793-798 .

Vizler C et al. (1999) Role of autoreactive CD8+ T cells in organ-specific autoimmune diseases: insight from transgenic mouse models . Immunol Rev 169: 81-92 .

Becher B et al. (1999) Interferon-g secretion by peripheral blood T-cell subsets in multiple sclerosis: correlation with disease phase and interferon-b therapy . Ann Neurol 45: 247-250 .

Balashov KE , Khoury SJ , Hafler DA , Weiner HL. (1995) Inhibition of T cell responses by activated human CD8+ T cells is mediated by interferon-gamma and is defective in chronic progressive multiple sclerosis . J Clin Invest 95: 2711-2719 .

Revesz T et al. (1994) A comparison of the pathology of primary and secondary progressive multiple sclerosis . Brain 29: 53-62 .

Lucchinetti CF , Bruck W , Rodriquez M , Lassmann H. (1996) Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis . Brain Pathol 6: 259-274 .

10.

Thompson AJ et al. (1997) Primary progressive multiple sclerosis . Brain 120: 1085-1096 .

11.

Duran EM et al. (1999) Immunologicalprofileofpatients with primary progressive multiple sclerosis. Expression of adhesion molecules . Brain 122: 2297-2307 .

12.

Weinshenker BG. (2000) Progressive forms of MS: classification streamlined or consensus overturned? Lancet 355: 162-163 .

13.

McDonnell GV et al. (1999) Serum soluble adhesion molecules in multiple sclerosis: raised sVCAM-1, sICAM-1 and sE-selectin in primary progressive disease . J Neurol 246: 87-92 .

14.

Prat A et al. (2000) Heterogeneity of T-lymphocyte function in primary progressive multiple sclerosis: relation to magnetic resonance imaging lesion volume . Ann Neurol 47: 234-237 .

15.

Lublin FD , Reingold SC. (1996) Defining the clinical course of multiple sclerosis: results of an international survey . Neurology 46: 907-911 .

16.

Prussin C. (1997) Cytokine flow cytometry: understanding cytokine biology at the single-cell level . JClin Immunol 17: 195-204 .

17.

Openshaw P et al. (1995) Heterogeneity of intracellular cytokine synthesis at the single cell level in polarized T helper 1 and T helper 2 populations . J Exp Med 182: 1357-1367 .

18.

Stevenson VL et al. (1999) Primary and transitional progressive MS: a clinical and MRI-cross-sectional study . Neurology 52: 839-845 .

19.

Weinshenker B et al. (1998) Major histocompatibility complex 2 alleles and the course and outcome of multiple sclerosis: a population-based study . Neurology 51: 742-747 .

20.

Storch M , Lassmann H. (1997) Pathogenesis of demyelinating diseases . Curr Opin Neurol 10: 186-192 .

21.

McKenzie GJ et al. (1999) Simultaneous disruption of IL- 4 and IL-13 defines individual roles in T helper cell type 2-mediated responses . J Exp Med 189: 1565-1572 .

22.

Hart PH et al. (1999) Differential responses of human monocytes and macrophages to IL-4 and IL-13 . J Leukocyte Biol 66: 575-578 .

23.

Panitch HS , Hirsch RL , Haley AS , Johnson KP. (1987) Exacerbations of multiple sclerosis in patients treated with gamma interferon . Lancet 1: 893-894 .

24.

Inoges S et al. (1999) Cytokine flow cytometry differentiates the clinical status of multiple sclerosis patients . Clin Exp Immunol 115: 521-525 .

25.

Nguyen LT et al. (1999) Flow cytometric analysis of in vitro proinflammatory cytokine secretion in peripheral blood from multiple sclerosis patients . J Clin Immunol 19: 179-185 .